Investor Webinar Presentation

For personal use only

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 [phone] www.nanoveu.com

ASX RELEASE	10 November 2021
	ASX: NVU

Investor Webinar Presentation

Nanoveu Limited ("Nanoveu") provided a shareholders and investors webinar on Wednesday 10 November 2021 at 12:30 pm AEDT / 9:30 WST.

A copy of the investor presentation delivered during the webinar is attached. - Ends -

This announcement has been authorised for release by Nanoveu's Managing Director and CEO

For further information, please	For media / investor enquiries,
contact:	please contact:
Alfred Chong	Jane Morgan
Executive Chairman and CEO	Investor Relations
t: [phone]	t: 0405 555 618
e: [e-mail]	e: [e-mail]

About Nanoveu Limited

We are technology innovators who specialize in modern, cutting-edge nanotechnology that improve the way we live, from reducing contagious transmissions on high touch points to immersive vision-based entertainment. https://www.nanoveu.com/

Nanoshield - is a film which uses a patented polymer of Cuprous embedded film to self-disinfect surfaces. Nanoshield antiviral protection which is available in a variety of shapes and forms, from mobile screen covers, to mobile phone cases and as a PVC commercial film, capable of being applied to a number of surfaces such as doorhandles and push panels. The perfectly clear plastic film contains a layer of charged copper nanoparticles which have antiviral and antimicrobial properties. This technology is also being applied to fabric applications targeting use in the personal protective equipment sector.

EyeFly3D - is a film applied to digital displays that allowed users to experience 3D without the need for glasses on everyday mobile handheld devices.

Customskins - are vending machines capable of precisely applying screen covers to mobile phones with an alignment accuracy of 150 microns.

EyeFyx - currently in research and development stage, EyeFyx is a vision correction solution using hardware and software to manipulate screen output addressing long-sightedness without the need to wear reading glasses.

ersonal use only

(ASX:NVU)

Cutting-edge antiviral nanotechnology reducing contagious transmissions on high touch points

INVESTOR PRESENTATION

NOVEMBER 2021

ersonal use only

DISCLOSURE AND DISCLAIMER

The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products.

This presentation does not constitute investment advice. Neither does this presentation nor the information contained in it constitute an offer, invitation, solicitation or recommendation in relation to the purchase or sale of shares in any jurisdiction. This presentation does not take into account any person's particular investment objectives, financial resources or other relevant circumstances and the opinions and recommendations in this presentation are not intended to represent recommendations of particular investments to particular persons. Nanoveu does not make any representation or warranty, express or implied, as to the accuracy or completeness of any information, statements, opinions, estimates, forecasts or other representations contained in this presentation. No responsibility for any errors or omissions from this presentation arising out of negligence or otherwise is accepted.

This presentation may include forward-looking statements. Forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions, which are outside the control of Nanoveu. Given these uncertainties, readers are cautioned not to place reliance on forward looking statements.

Any forward looking statements in this presentation speak only at the date of issue of this presentation subject to any continuing obligations under applicable law, Nanoveu does not undertake any obligation to update or revise any information or any of the forward looking statements in this presentation only changes in events, conditions or circumstances on which any such forward looking statement is based.

This document is provided for information purposes only. It is not an offer of sale nor a solicitation of any kind. It is recommended that anybody reviewing the statements here with a view for investment obtain independent professional advice.

2

ersonal use only

COMPANY OVERVIEW

Nanoveu Limited	(ASX:NVU) is a leading technology innovation
Board & Management
company specialised in modern, cutting-edge nanotechnology that
improves the way we live, by reducing contagious transmissions	Scoot Beeton	Chairman & Non-Executive Director
on high touch points to immersive vision-based entertainment.
Alfred Chong	Chief Executive Officer
The Company's	recently commercialised NanosheildTM film is
Michael van Uffelen	Executive Director, CFO, Company
invisible and proven to eliminate 99% of viruses within minutes1,	Secretary
including Coronavirus strains.	Steven Apedaile	Non-Executive Director
Following the development of an antiviral spray, in October 2021,
David Nicol	Non-Executive Director
the Company entered	a Licensing and Research Collaboration
Capital Structure
Agreement with Nanyang Technological University Singapore,
further advancing Nanoveu's strategy to create a full range of	ASX Code			NVU
effective self-disinfecting solutions and expand the Nanoshield™
Shares on Issue			209.16m
range of products.
				Performance Rights			8.93m
Shareholder Breakdown
Options on Issue			16.33m2
							Share Price (as 9 November 2021)		A$0.043
56.0%		Top 20 Shareholders*
Share Price - 52 Week Trading Range		$0.036 - $0.085
22.5%		Board and Management			Market Capitalisation			A$8.99m
							Cash (30 September 2021)		~A$2.0 million
							Number of shareholders (9 November 2021)		902		3
*Including Board & Management
1 See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 July 2021 for the testing performed and the results.

2 $0.058 - $0.20 exercise price with expiry 11/2021 - 9/2023

INVESTMENT HIGHLIGHTS

ersonal use only

Recently appointed Chairman in Australia leading stakeholder management, with a new COO appointed to drive further growth and product development.

Successful commercialisation of Nanoshield™ with Nestlé Group's Professional Services Unit secured as a flagship customer providing revenue and product validation from a tier 1 global company.

Strong international distribution network for Nanoshield™ and discussions continuing with interested parties globally to drive further growth.

Licensing and Research Collaboration Agreement with NTU Singapore, following the successful development of a new spray formulation for enterprise scale antiviral and antibacterial textile treatment.

Strong product development pipeline with low capital investment for new products and an expanded product range year-on-year.

Antiviral and antibacterial products are a high growth market, with the global anti-microbial coating market valued at $8.0b in 2020 and forecast to grow at a CAGR or 13.1% to $53.5b in 2028.1

1 - https://www.grandviewresearch.com/industry-analysis/antimicrobial-coatings-market

4